LOBEGLITONE 0.5 Lobeglitazone Sulfate 0.5 mg used in the management of type 2 diabetes, especially help to control blood sugar levels in adults. In the ever-evolving landscape of diabetes treatment, Lobeglitone 0.5 emerges as a beacon of hope and innovation. Engineered to address the multifaceted challenges of diabetes mellitus, this groundbreaking medication represents a paradigm shift in therapeutic approach and patient care. At its essence, Lobeglitone 0.5 embodies the culmination of extensive research and technological advancement, offering a novel mechanism of action that sets it apart from conventional treatments. As a potent and selective agonist of peroxisome proliferator-activated receptor gamma (PPARγ), Lobeglitone 0.5 exerts its effects by enhancing insulin sensitivity, promoting glucose uptake, and regulating lipid metabolism. This unique mode of action not only helps to control blood sugar levels but also addresses key underlying factors contributing to the progression of diabetes, such as insulin resistance and dyslipidemia. Furthermore, Lobeglitone 0.5 distinguishes itself through its favorable safety and tolerability profile, providing patients and healthcare providers with a valuable treatment option that minimizes the risk of adverse effects and complications. With its once-daily dosing regimen and convenient administration, Lobeglitone 0.5 offers convenience and simplicity without compromising efficacy or patient adherence.
| Active Ingredient: | Lobeglitazone Sulfate 0.5 Mg |
| Country of origin | INDIA |
| Brand Name: | LOBEGLITONE 0.5 |
| Dosage | As Directed By The Physician |
| Storage | Store Protected From Light & Moisture |
| Packaging Size | 10*10 Tablets |
| Manufactured By | Steris Healthcare Pvt Ltd |